
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (20): 2516-2522.DOI: 10.12114/j.issn.1007-9572.2024.0072
Special Issue: 呼吸疾病文章合辑
• Original Research • Previous Articles Next Articles
Received:2024-02-17
Revised:2024-08-26
Published:2025-07-15
Online:2025-05-28
Contact:
XING Qing
通讯作者:
邢卿
作者简介:作者贡献:
荆晨晨提出主要研究的思路并设计研究方案,撰写论文;荆晨晨、王艳如、徐辉辉进行数据的收集与整理,统计学处理,图、表的绘制与展示;王淑娟进行论文的修订;刑卿负责文章的质量控制与监督管理,对文章整体负责。
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0072
| 时间 | ROX指数 | VOX指数 |
|---|---|---|
| 基线水平 | 0.068 6±0.017 5 | 0.007 6±0.000 8 |
| 第1个8 h | 0.077 6±0.023 8a | 0.007 2±0.000 9a |
| 第2个8 h | 0.084 7±0.018 9ab | 0.006 7±0.000 6ab |
| 第3个8 h | 0.099 6±0.014 1abc | 0.005 9±0.000 4abc |
| F值 | 638.609 | 196.409 |
| P值 | <0.001 | <0.001 |
Table 1 Comparison of ROX index and VOX index within 24 hours of NlPPV in the research subjects
| 时间 | ROX指数 | VOX指数 |
|---|---|---|
| 基线水平 | 0.068 6±0.017 5 | 0.007 6±0.000 8 |
| 第1个8 h | 0.077 6±0.023 8a | 0.007 2±0.000 9a |
| 第2个8 h | 0.084 7±0.018 9ab | 0.006 7±0.000 6ab |
| 第3个8 h | 0.099 6±0.014 1abc | 0.005 9±0.000 4abc |
| F值 | 638.609 | 196.409 |
| P值 | <0.001 | <0.001 |
| 项目 | 基线ROX指数 | 基线VOX指数 | 吸痰前1 h ROX指数 | 吸痰前1 h VOX指数 | ||||
|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
| SpO2剧烈下降发生率 | -0.771 | <0.001 | 0.483 | <0.001 | -0.702 | <0.001 | 0.445 | <0.05 |
| SpO2剧烈下降持续时间 | -0.740 | <0.001 | 0.688 | <0.001 | -0.748 | <0.001 | 0.516 | <0.001 |
Table 2 Partial correlation analysis of ROX index,VOX index and sharp decline of SpO2
| 项目 | 基线ROX指数 | 基线VOX指数 | 吸痰前1 h ROX指数 | 吸痰前1 h VOX指数 | ||||
|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | r值 | P值 | |
| SpO2剧烈下降发生率 | -0.771 | <0.001 | 0.483 | <0.001 | -0.702 | <0.001 | 0.445 | <0.05 |
| SpO2剧烈下降持续时间 | -0.740 | <0.001 | 0.688 | <0.001 | -0.748 | <0.001 | 0.516 | <0.001 |
| 项目 | 例数 | 基线ROX指数 | 吸痰前1 h ROX指数 | ||||
|---|---|---|---|---|---|---|---|
| 数值 | t值 | P值 | 数值 | t值 | P值 | ||
| SpO2剧烈下降 | 20.22 | <0.001 | 18.71 | <0.001 | |||
| 是 | 98 | 0.058 5±0.007 2 | 0.053 5±0.005 3 | ||||
| 否 | 42 | 0.092 2±0.009 7 | 0.071 5±0.004 9 | ||||
| 吸痰前SpO2<85% | -11.77 | <0.001 | -12.93 | <0.001 | |||
| 是 | 67 | 0.056 0±0.004 7 | 0.051 4±0.003 6 | ||||
| 否 | 73 | 0.080 2±0.016 8 | 0.065 7±0.008 6 | ||||
| 吸痰后最低SpO2<80% | -23.06 | <0.001 | -17.22 | <0.001 | |||
| 是 | 105 | 0.059 7±0.008 3 | 0.054 2±0.005 9 | ||||
| 否 | 35 | 0.095 5±0.006 8 | 0.072 8±0.004 2 | ||||
| SpO2剧烈下降持续时间>15 s | 20.30 | <0.001 | 22.47 | <0.001 | |||
| 是 | 85 | 0.056 0±0.003 6 | 0.051 8±0.003 2 | ||||
| 否 | 55 | 0.088 1±0.011 3 | 0.069 8±0.005 3 | ||||
| SpO2剧烈下降发生率≥60% | 19.51 | <0.001 | 18.68 | <0.001 | |||
| 是 | 96 | 0.058 2±0.007 0 | 0.053 3±0.005 2 | ||||
| 否 | 44 | 0.091 4±0.010 2 | 0.071 0±0.005 2 | ||||
Table 3 Comparison of ROX index in different groups of patients
| 项目 | 例数 | 基线ROX指数 | 吸痰前1 h ROX指数 | ||||
|---|---|---|---|---|---|---|---|
| 数值 | t值 | P值 | 数值 | t值 | P值 | ||
| SpO2剧烈下降 | 20.22 | <0.001 | 18.71 | <0.001 | |||
| 是 | 98 | 0.058 5±0.007 2 | 0.053 5±0.005 3 | ||||
| 否 | 42 | 0.092 2±0.009 7 | 0.071 5±0.004 9 | ||||
| 吸痰前SpO2<85% | -11.77 | <0.001 | -12.93 | <0.001 | |||
| 是 | 67 | 0.056 0±0.004 7 | 0.051 4±0.003 6 | ||||
| 否 | 73 | 0.080 2±0.016 8 | 0.065 7±0.008 6 | ||||
| 吸痰后最低SpO2<80% | -23.06 | <0.001 | -17.22 | <0.001 | |||
| 是 | 105 | 0.059 7±0.008 3 | 0.054 2±0.005 9 | ||||
| 否 | 35 | 0.095 5±0.006 8 | 0.072 8±0.004 2 | ||||
| SpO2剧烈下降持续时间>15 s | 20.30 | <0.001 | 22.47 | <0.001 | |||
| 是 | 85 | 0.056 0±0.003 6 | 0.051 8±0.003 2 | ||||
| 否 | 55 | 0.088 1±0.011 3 | 0.069 8±0.005 3 | ||||
| SpO2剧烈下降发生率≥60% | 19.51 | <0.001 | 18.68 | <0.001 | |||
| 是 | 96 | 0.058 2±0.007 0 | 0.053 3±0.005 2 | ||||
| 否 | 44 | 0.091 4±0.010 2 | 0.071 0±0.005 2 | ||||
| 项目 | 例数 | 基线VOX指数 | 吸痰前1 h VOX指数 | ||||
|---|---|---|---|---|---|---|---|
| 数值 | t值 | P值 | 数值 | t值 | P值 | ||
| SpO2剧烈下降 | -13.77 | <0.001 | -8.99 | <0.001 | |||
| 是 | 98 | 0.007 9±0.000 5 | 0.010 7±0.002 2 | ||||
| 否 | 42 | 0.006 7±0.000 4 | 0.008 3±0.001 0 | ||||
| 吸痰前SpO2<85% | 8.322 | <0.001 | 4.98 | <0.001 | |||
| 是 | 67 | 0.008 0±0.000 5 | 0.010 9±0.002 6 | ||||
| 否 | 73 | 0.007 1±0.000 7 | 0.009 1±0.001 3 | ||||
| 吸痰后最低SpO2下降<80% | 16.957 | <0.001 | 11.00 | <0.001 | |||
| 是 | 105 | 0.007 9±0.000 6 | 0.010 7±0.002 1 | ||||
| 否 | 35 | 0.006 6±0.000 3 | 0.008 0±0.000 8 | ||||
| SpO2剧烈下降持续时间>15s | -14.53 | <0.001 | -6.40 | <0.001 | |||
| 是 | 85 | 0.008 0±0.000 5 | 0.010 8±0.002 3 | ||||
| 否 | 55 | 0.006 8±0.000 5 | 0.008 7±0.001 2 | ||||
| SpO2剧烈下降发生率≥60% | -13.40 | <0.001 | -8.40 | <0.001 | |||
| 是 | 96 | 0.007 9±0.000 5 | 0.010 7±0.002 2 | ||||
| 否 | 44 | 0.006 7±0.000 4 | 0.008 4±0.001 1 | ||||
Table 4 Comparison of VOX index in different groups of patients
| 项目 | 例数 | 基线VOX指数 | 吸痰前1 h VOX指数 | ||||
|---|---|---|---|---|---|---|---|
| 数值 | t值 | P值 | 数值 | t值 | P值 | ||
| SpO2剧烈下降 | -13.77 | <0.001 | -8.99 | <0.001 | |||
| 是 | 98 | 0.007 9±0.000 5 | 0.010 7±0.002 2 | ||||
| 否 | 42 | 0.006 7±0.000 4 | 0.008 3±0.001 0 | ||||
| 吸痰前SpO2<85% | 8.322 | <0.001 | 4.98 | <0.001 | |||
| 是 | 67 | 0.008 0±0.000 5 | 0.010 9±0.002 6 | ||||
| 否 | 73 | 0.007 1±0.000 7 | 0.009 1±0.001 3 | ||||
| 吸痰后最低SpO2下降<80% | 16.957 | <0.001 | 11.00 | <0.001 | |||
| 是 | 105 | 0.007 9±0.000 6 | 0.010 7±0.002 1 | ||||
| 否 | 35 | 0.006 6±0.000 3 | 0.008 0±0.000 8 | ||||
| SpO2剧烈下降持续时间>15s | -14.53 | <0.001 | -6.40 | <0.001 | |||
| 是 | 85 | 0.008 0±0.000 5 | 0.010 8±0.002 3 | ||||
| 否 | 55 | 0.006 8±0.000 5 | 0.008 7±0.001 2 | ||||
| SpO2剧烈下降发生率≥60% | -13.40 | <0.001 | -8.40 | <0.001 | |||
| 是 | 96 | 0.007 9±0.000 5 | 0.010 7±0.002 2 | ||||
| 否 | 44 | 0.006 7±0.000 4 | 0.008 4±0.001 1 | ||||
| 项目 | AUC | 95%CI | 标准误 | 最佳截断值 | 灵敏度 | 特异度 | Youden指数 |
|---|---|---|---|---|---|---|---|
| 基线VOX指数 | 0.970 | 0.939~0.967 | 0.016 | 0.007 4 | 0.898 | 0.976 | 0.874 |
| 吸痰前1 h VOX指数 | 0.893 | 0.826~0.959 | 0.034 | 0.008 7 | 0.969 | 0.786 | 0.755 |
Table 5 Results of ROC curve analysis of baseline VOX index and pre-sputum 1 h VOX index in predicting sharp drop in SpO2
| 项目 | AUC | 95%CI | 标准误 | 最佳截断值 | 灵敏度 | 特异度 | Youden指数 |
|---|---|---|---|---|---|---|---|
| 基线VOX指数 | 0.970 | 0.939~0.967 | 0.016 | 0.007 4 | 0.898 | 0.976 | 0.874 |
| 吸痰前1 h VOX指数 | 0.893 | 0.826~0.959 | 0.034 | 0.008 7 | 0.969 | 0.786 | 0.755 |
| [1] |
|
| [2] |
孔德昭,王科雯,罗文晔,等. 慢性阻塞性肺疾病急性加重期诊疗指南评价与综合分析[J]. 中国中医基础医学杂志,2023,29(8):1307-1317.
|
| [3] |
谭旭,许娟,罗薇娜,等. 两种气道廓清技术在慢性阻塞性肺疾病急性加重病人中的应用效果比较[J]. 护理研究,2020,34(9):1662-1665. DOI:10.12102/j.issn.1009-6493.2020.09.039.
|
| [4] |
丁亚平,夏姗姗,童祥飞,等. 2022版《AARC临床实践指南:人工气道内吸痰》解读[J]. 护理研究,2022,36(22):3953-3957. DOI:10.12102/j.issn.1009-6493.2022.22.002.
|
| [5] |
|
| [6] |
梁娟. ICU人工气道患者吸痰并发症分析及不同吸痰深度效果比较研究[D]. 西安:第四军医大学,2017.
|
| [7] |
|
| [8] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志,2021,44(3):170-205. DOI:10.3760/cma.j.cn112147-20210109-00031.
|
| [9] |
张红,陈秀文,郭佳,等. 慢性阻塞性肺疾病患者氧疗管理的证据总结[J]. 中华护理教育,2021,18(8):736-742. DOI:10.3761/j.issn.1672-9234.2021.08.014.
|
| [10] |
张艳红,罗彩凤,米元元,等. 慢性阻塞性肺疾病患者长期氧疗管理的最佳证据总结[J]. 护理学报,2021,28(15):35-41. DOI:10.16460/j.issn1008-9969.2021.15.035.
|
| [11] |
程伟鹤. 机械通气患者腹内压与肠内营养喂养不耐受的相关性研究[D]. 北京:北京协和医学院,2017.
|
| [12] |
中华护理学会. 成人有创机械通气气道内吸引技术操作:T/CNAS 10-2020[S]. 北京:中国标准出版社,2021.
|
| [13] |
|
| [14] |
|
| [15] |
王金荣,高攀,商会棉,等. 早期集束化气道清理技术联合无创通气治疗肺性脑病临床研究[J]. 国际呼吸杂志,2018,38(19):1482-1490. DOI:10.3760/cma.j.issn.1673-436X.2018.19.009.
|
| [16] |
中国医师协会急诊医师分会,中国医疗保健国际交流促进会急诊急救分会,国家卫生健康委能力建设与继续教育中心急诊学专家委员会. 无创正压通气急诊临床实践专家共识(2018)[J]. 中华急诊医学杂志,2019,28(1):14-24. DOI:10.3760/cma.j.issn.1671-0282.2019.01.004.
|
| [17] |
王浩,马娟珍,陈华丽,等. 无创通气状态下不同吸入氧浓度对AECOPD患者血气结果的影响[J]. 山东医药,2013,53(16):54-55. DOI:10.3969/j.issn.1002-266X.2013.16.021.
|
| [18] |
陶琳,万群芳,吴小玲,等. 四川省30家综合医院无创正压通气治疗过程中供氧浓度和吸入氧浓度的调查研究[J]. 中国现代医学杂志,2018,28(6):65-70. DOI:10.3969/j.issn.1005-8982.2018.06.012.
|
| [19] |
王金荣,高攀,郭淑芬,等. 慢性阻塞性肺疾病无创通气期间高浓度吸氧对二氧化碳分压的影响[J]. 中国呼吸与危重监护杂志,2016,15(4):329-332. DOI:10.7507/1671-6205.2016078.
|
| [20] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病急性加重高风险患者识别与管理中国专家共识[J]. 国际呼吸杂志,2022,42(24):1845-1863. DOI:10.3760/cma.j.cn131368-20221030-00961.
|
| [21] |
|
| [22] |
|
| [23] |
彭瑜. ICU机械通气患者吸痰致低氧血症的护理研究进展[J]. 当代护士(上旬刊),2022,29(1):30-32. DOI:10.19791/j.cnki.1006-6411.2022.01.009.
|
| [24] |
李珂,李楠,邓兰芬. 机械通气患者吸痰致低氧血症的护理干预研究进展[J]. 中华护理杂志,2011,46(6):630-632. DOI:10.3761/j.issn.0254-1769.2011.06.044.
|
| [25] |
于丹,王金荣,崔朝勃. 重症监护病房无创通气与高流量氧疗,如何选择[J]. 国际呼吸杂志,2019,39(17):1338-1343. DOI:10.3760/cma.j.issn.1673-436X.2019.17.010.
|
| [1] | WANG Longyu, LI Ya, MA Qian, JIA Peilin, ZHANG Hailong. Clinical Application Progress of Diffusing Capacity of the Lung for Carbon Monoxide in Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2026, 29(23): 3379-3384. |
| [2] | CHEN Dian, LONG Huanyu, CHU Lanhe, JIANG Yixia, GUO Wanjin, NIU Yang, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2026 Report [J]. Chinese General Practice, 2026, 29(21): 2913-2932. |
| [3] | ZHAO Xuedan, AI Yue, JIN Guoen, JIA Guoqiang. The New Research Progress of Non-infectious Lung Diseases in High Altitude Areas [J]. Chinese General Practice, 2026, 29(14): 1931-1938. |
| [4] | YANG Fangting, XU Junfeng, YANG Qin, MA Yingzhi, ZHOU Ling, XIAO Jiangqin. Analysis of the Current Situation and Influencing Factors of Intolerance of Uncertainty in AECOPD Patients under the Perspective of Health Ecology [J]. Chinese General Practice, 2026, 29(11): 1434-1440. |
| [5] | TIAN Ying, PAN Dianzhu. Analysis of Related Factors of Renal Function Impairment in AECOPD Patients [J]. Chinese General Practice, 2026, 29(07): 885-892. |
| [6] | CHEN Xueqin, WANG Shihong, LAI Fengxia, ZHANG Jingjing, CHEN Hao, KONG Danli, DING Yuanlin. Study on Trend Analysis and Forecast of Incidence, Disease and Mortality of Chronic Obstructive Pulmonary Disease in China, 1990-2021 [J]. Chinese General Practice, 2026, 29(02): 264-272. |
| [7] | TAN Huihui, MAO Wei, YANG Zihan. Research Progress of Annexin A1 in Respiratory Diseases [J]. Chinese General Practice, 2025, 28(13): 1668-1673. |
| [8] | CHU Hongling, LI Shurun, LI Xinlin, CHEN Yahong. Current Status of Implementation of Patient Involvement in Health Care to Improve Quality of Care among Chronic Obstructive Pulmonary Disease: a Scoping Review [J]. Chinese General Practice, 2025, 28(02): 228-233. |
| [9] | YU Chunyan, DONG Fen, LEI Jieping, YANG Ting, XIA Jingen, QUMU Shiwei, YANG Tianyi, LI Xiaopan. Correlation between Body Composition and Cardiopulmonary Exercise Capacity in Patients with Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2024, 27(29): 3629-3634. |
| [10] | HUANG Jinhai, LI Yun, GAO Yi. Research Progress on Chest CT Features of the Preserved Ratio Impaired Spirometry Population [J]. Chinese General Practice, 2024, 27(29): 3679-3684. |
| [11] | LI Xingyang, SUN Wanqi, YIN Mengjie, DOU Tingting, LYU Yili, XU Wei, ZHA Zhenqiu. Sleep Quality and Anxiety and Depression in Patients with Chronic Obstructive Pulmonary Disease and Their Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2024, 27(20): 2437-2444. |
| [12] | GAO Sijie, CHEN Zelin, WU Siyu, WANG Zheng, MENG Aihong. Clinical Characteristics of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Asthma-chronic Obstructive Pulmonary Disease Overlap Patients with Different Low Attenuation Area Grades [J]. Chinese General Practice, 2024, 27(12): 1468-1474. |
| [13] | CHANG Chun, SUN Yongchang. Global Strategy for Asthma Management and Prevention: Interpretation of the Updates in 2022 [J]. Chinese General Practice, 2022, 25(35): 4355-4362. |
| [14] | Li DU, Xiaohua XIONG, Fangfang DUAN, Xue REN, Chunju YANG, Yiting GUAN, Peipei WANG. Prevalence of Acceptance of Noninvasive Positive-pressure Ventilation and Associated Factors in Hainan Adult Population with Obstructive Sleep Apnea-hypopnea Syndrome [J]. Chinese General Practice, 2022, 25(27): 3414-3421. |
| [15] | Writing Group for the Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease. Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2022, 25(24): 2947-2959. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||